Validation of a Multitask Deep Learning System at Spine Metastasis CT

Sponsor
Shanghai 6th People's Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05156567
Collaborator
(none)
420
18

Study Details

Study Description

Brief Summary

The multitask deep learning system (DLS) with five algorithms detecting five quantitative factors of Spinal Instability Neoplastic Score (SINS) was developed. Radiologists and oncologists from multicenter will be recruited to read the CT scans in picture archiving and communication system (PACS) independently, comparing with the DLS. One month after reading the CT scans in PACS, the participants will also asked to perform a web-based test in the DLS website using the same CT scans. Area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of the DLS were calculated with professional graders as the reference standard.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Deep Learning System

Study Design

Study Type:
Observational
Anticipated Enrollment :
420 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Multicenter Validation of a Multitask Deep Learning System for Spinal Instability at Spine Metastasis CT
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
routine physicians

Diagnostic Test: Deep Learning System
The multitask DLS with five algorithms detecting five quantitative factors of SINS

DLS

Diagnostic Test: Deep Learning System
The multitask DLS with five algorithms detecting five quantitative factors of SINS

Outcome Measures

Primary Outcome Measures

  1. AUC [1 months]

    Area under the receiver operating characteristic curve (AUC) of spinal instability detection

Secondary Outcome Measures

  1. sensitivity [1 months]

    sensitivity of spinal instability detection

  2. specificity [1 months]

    specificity of spinal instability detection

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. pathology-proven diagnosis of solid tumor;

  2. spinal CT scan indicating spinal metastasis with at least one lesion;

  3. no previous surgery for spinal metastasis

Exclusion Criteria:
  1. spinal CT scans with no sagittal reconstruction;

  2. the radiologist considered that the quality of CT image was unqualified.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Shanghai 6th People's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhao Hui, Dr, Shanghai 6th People's Hospital
ClinicalTrials.gov Identifier:
NCT05156567
Other Study ID Numbers:
  • DLS01
First Posted:
Dec 14, 2021
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022